Novel excipient regulatory pathway addresses substances lacking established safety profiles requiring additional testing. Toxicology studies establish acceptable safety limits. Clinical tolerance assessment evaluates human safety. Regulatory submissions provide comprehensive characterisation. Approval timelines extend from limited regulatory precedent.
Excipient innovation enables improved formulation performance. Safety profiles sometimes provide novel therapeutic benefits. Patent protection encourages excipient innovation. Regulatory guidance evolves addressing novel substances. International harmonisation reduces redundant testing.
Regulatory Affairs
Novel Excipient Regulatory Pathway
A novel excipient regulatory pathway defines the regulatory requirements for evaluating the safety and approval of previously unapproved pharmaceutical excipients.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →